I have not seen any news about options re-pricing. Any such action would have to show up in the annual financial report, possibly as a footnote. While I would have no issue whatsoever with Noront doing so for the folks you mention, the company that I work for has resisted mightily any options re-pricing as being unfair to the shareholders.

If push came to shove, I'd much rather suck up the dilution of re-pricing options for "the old guard" than risk <shudder> losing any of them. They are *that* good.